FILE PHOTO: Former U.S. President Donald Trump speaks at the Conservative Political Action Conference (CPAC) in Orlando, Florida, U.S. February 28, 2021. REUTERS/Joe Skipper/File Photo

President Donald J. Trump has received a COVID-19 booster shot and flu vaccination, according to his physician’s medical report released by the White House. The document states that the president underwent a comprehensive health evaluation at Walter Reed National Military Medical Center, including advanced imaging, laboratory testing, and preventive health assessments. The visit included annual influenza and updated COVID-19 booster vaccinations in preparation for upcoming international travel.

The report highlights that Trump’s cardiac age—measured via ECG—was approximately 14 years younger than his chronological age, with stable metabolic, hematologic, and cardiac parameters. His overall health was described as “exceptional,” with no restrictions on his demanding schedule.

The decision to administer the booster has sparked scrutiny, particularly given Trump’s previous skepticism toward public health measures. The article notes his recent criticism of pharmaceutical companies and Operation Warp Speed, suggesting a potential shift in his stance. However, the physician’s report underscores the administration’s continued reliance on medical protocols, despite growing public dissent over vaccine policies.

The text also references an earlier statement by Trump, in which he called for transparency from drug manufacturers regarding the efficacy of COVID-19 treatments. He questioned why results from companies like Pfizer were not made publicly available, framing the issue as a matter of accountability.

While the article acknowledges Trump’s evolving perspective on Big Pharma, it emphasizes his repeated endorsement of vaccination programs during his presidency, including the rapid development and distribution of vaccines under Operation Warp Speed. The narrative underscores persistent tensions between his leadership and segments of the public who distrust pharmaceutical institutions.